针刺联合中医电子辅助失眠认知行为疗法治疗慢性失眠:随机对照试验研究方案
本研究为单中心、开放标签、随机对照试验,拟招募90例受试者按1:1:1随机分为针刺组、中医电子辅助失眠认知行为疗法(TCM-eCBT-I)组及针刺联合TCM-eCBT-I组,评估匹兹堡睡眠质量指数(PSQI)等量表,结局在0、4、8、16、28周在线评估,旨在为临床提供更有效方案。
要点
- 针刺与CBT-I均为安全有效的非药物疗法,但针刺长期疗效不稳定,CBT-I复杂耗时且依从性低。
- 研究构建适合中国人的TCM-eCBT-I,并联合针刺以维持长期疗效,比较三种干预。
- 主要评估工具包括PSQI、DBAS、ISI、睡眠日记、HAMA、HAMD及FS-14。
核心结论
- 研究旨在评价针刺、TCM-eCBT-I及两者联合三种干预,为临床提供更有效的慢性失眠治疗方案。
研究设计与样本
- 单中心、开放标签、随机对照试验,拟招募90例受试者,按1:1:1随机分为针刺组、TCM-eCBT-I组和针刺联合TCM-eCBT-I组。
- 结局在0周、4周、8周、16周和28周在线评估。
- 研究已获南京中医药大学附属医院伦理委员会批准(2020 NL-018-02),并在中国临床试验注册中心注册(ChiCTR2000032960,注册日期2020年5月17日)。
关键数值与推荐
- 评估工具包括匹兹堡睡眠质量指数(PSQI)、睡眠信念与态度量表(DBAS)、失眠严重程度指数(ISI)、睡眠日记、汉密尔顿焦虑量表(HAMA)、汉密尔顿抑郁量表(HAMD)和疲劳量表-14(FS-14)。
- 所有不良反应用不良事件表评估。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The incidence of insomnia is getting higher and higher. Long-term insomnia seriously affects people's health. Drug use is usually accompanied with adverse events. Both acupuncture and cognitive behavioral therapy for insomnia (CBT-I) have been proven to be safe and effective non-pharmacological treatments for insomnia. As the insomniacs' bad sleep behavior and wrong cognition have not been effectively corrected, acupuncture has a quick effect, high patient compliance but unstable long-term efficacy, while CBT-I is complex, time-consuming, and expensive; additionally, patient compliance is low, and the number of trained therapists is limited, making it difficult to carry out. Therefore, this study aims to use the insomnia TCM system to construct a convenient and feasible traditional Chinese medicine e-aid cognitive behavioral therapy for insomnia (TCM-eCBT-I) for Chinese people, and combine the advantages of acupuncture and TCM-eCBT-I for maintaining long-term efficacy, and three treatments will be evaluated to provide clinicians with a more effective clinical protocol METHODS AND ANALYSIS: This study is a single-center, open-label, randomized controlled trial. Ninety subjects will be recruited and randomly assigned to three groups: the acupuncture group, the TCM-eCBT-I group, and the acupuncture combined with TCM-eCBT-I group, in a ratio of 1:1:1. We will evaluate the Pittsburgh Sleep Quality Index (PSQI) and Dysfunctional Beliefs and Attitudes About Sleep Scale (DBAS), Insomnia Severity Index (ISI), sleep diary, Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), and Fatigue Scale-14 Scale (FS-14) scales. All adverse reactions will be assessed through the ADVERSE event table. All outcomes will be evaluated online at 0 weeks, 4 weeks, 8 weeks, 16 weeks, and 28weeks. ETHICS AND DISSEMINATION: This study has been approved by the Institutional Review Board of the Affiliated Hospital of Nanjing University of Chinese Medicine (2020 NL-018-02). Informed consent will be obtained from all the subjects. The results will be shared with sleep researchers, public, and relevant academic institutions through high-impact peer-reviewed publications. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2000032960. Registered on 17 May 2020.
引用
- Liu CY, Zhao YN, Wang XQ, et al. Acupuncture combined with traditional Chinese medicine e-aid cognitive behavioral therapy for insomnia (TCM-eCBT-I) for chronic insomnia: study protocol for a randomized controlled trial. Trials. 2022. PMID: 35090540. doi:10.1186/s13063-022-06012-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。